Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 74 results
Author [ Title(Desc)] Year
Filters: First Letter Of Last Name is L and Author is Li, Yimei  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
O'Connor MJ, Zhang X, Griffis H, et al. "Center Variation in Indication and Short-Term Outcomes after Pediatric Heart Transplantation: Analysis of a Merged United Network for Organ Sharing - Pediatric Health Information System Cohort." Pediatr Cardiol. 2021.
Miller TP, Li Y, Kavcic M, et al. "Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: A report from the Children's Oncology Group." Haematologica. 2017.
Hill DL, Faerber JA, Li Y, et al. "Changes Over Time in Good-Parent Beliefs Among Parents of Children with Serious Illness: A Two-Year Cohort Study." J Pain Symptom Manage. 2019.
Arnold SD, Brazauskas R, He N, et al. "Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the U.S. using merged databases." Haematologica. 2017;102(11):1823-1832.
Li Y, Newton JG, Getz KD, et al. "Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia." Pediatr Blood Cancer. 2018:e27583.
Vujkovic M, Aplenc R, Alonzo TA, Gamis AS, Li Y. "Comparing Analytic Methods for Longitudinal GWAS and a Case-Study Evaluating Chemotherapy Course Length in Pediatric AML. A Report from the Children's Oncology Group." Front Genet. 2016;7:139.
Miller TP, Troxel AB, Li Y, et al. "Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(7):1184-9.
Miller TP, Getz KD, Kavcic M, et al. "A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group." Leuk. Lymphoma. 2016:1-8.
Getz KD, Li Y, Alonzo TA, et al. "Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(10):1775-81.
Getz KD, Miller TP, Seif AE, et al. "A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia." Cancer Med. 2015;4(9):1356-64.
Winestone LE, Getz KD, Miller TP, et al. "Complications preceding early deaths in Black and White children with acute myeloid leukemia." Pediatr Blood Cancer. 2017.
DiNofia AM, Seif AE, Devidas M, et al. "Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232." Cancer Med. 2018;7(1):3-12.
Citrin R, Horowitz JP, Reilly AF, et al. "Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database." PLoS ONE. 2017;12(10):e0186960.

Pages